Manufacturer record
Zee Laboratories Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
52 batches manufactured by Zee Laboratories Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
52 records linked to Zee Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
0Banned or prohibited
0Recalled or suspended
52Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
52
NSQ batches since 2019
46
Products affected
Assay
Most common failure
Jun 2026
Latest alert
Flagged batches per year
2019 · 32020 · 12021 · 62022 · 72023 · 102024 · 82025 · 122026 · 5
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Gentamicin Eye/Ear Drops 5 ml | 1224-226Mfg 2024-06 · Exp 2026-05 | The sample does not conform to Manufacturer's specification with respect to test for Particulate MatterParticulate matter | CDL KolkataCDSCO lab | Jun 2026 |
| Allopurinol Tablets IP 100mg | 425-2191Mfg 2025-10 · Exp 2027-09 | AssayAssay | DTL, ThiruvananthapuramState lab | Mar 2026 |
| Allopurinol Tablets I.P. 100 MG | 425-1324Mfg 2025-06 · Exp 2027-05 | The sample does not conform to I.P with respect to Assay of Allopurinol.Assay | CDL, KolkataCDSCO lab | Mar 2026 |
| Bacillus clausii spores suspension | Z24-450Mfg 2024-06 · Exp 2026-05 | The sample received does not conform toclaim with respect to Assay of Bacillus Clausii and Description.Assay | CDTL, MumbaiCDSCO lab | Jan 2026 |
| Amlodipine Tablets I.P. 2.5 mg | 424-1521Mfg 2024-08 · Exp 2026-07 | The sample is not of standard quality for the reason stated under Description of the tabletsDescription | RDTL,GuwahatiCDSCO lab | Jan 2026 |
| Arik Syrup (Ambroxol Hydrochloride, Phenylephrine Hydrochloride, chlorpheniramine Maleate Guaiphenesin & Menthol Syrup) | 624-732Mfg 2024-10 · Exp 2026-09 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Oct 2025 |
| Tranexamic Acid Injection IP 500 mg/5ml | Z24-185Mfg 2024-02 · Exp 2026-01 | Related Substances and Assay of Tranexamic AcidAssay | CDL KolkataCDSCO lab | Jun 2025 |
| Glipizide & Metformin Tablets I.P | Z24-011Mfg 2024-01 · Exp 2026-12 | DescriptionDescription | CDTL IndoreCDSCO lab | Jun 2025 |
| Sucralfate Oral Suspension (AXID 200) | 624-470Mfg 2024-06 · Exp 2026-05 | The sample does not conform to claim standards with respect to descriptionDescription | CDTL- ChennaiCDSCO lab | May 2025 |
| Povidone Iodine Gargle 2% (ZEVODINE) | 623-864Mfg 2023-11 · Exp 2025-10 | Test For Assay (Content) of Povidone-Iodine Equivalent To Available-IodineAssay | Government of NCT of DelhiState lab | May 2025 |
| Axid 200 (Sucralfate Oral Suspension) | 624-470Mfg 2024-06 · Exp 2026-05 | Sample does not conform with respect to General requirements for liquid dosage formOther | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Omeprazole for Injection (Lyophilized) 40 mg (Fexona ) | 324-609Mfg 2024-05 · Exp 2027-04 | Sterility of Water for InjectionSterility | CDL, KolkataCDSCO lab | Mar 2025 |
| Omeprazole for Injection (Lyophilized) 40 mg (Fexona ) | 324-608Mfg 2024-05 · Exp 2027-04 | Sterility of Water for InjectionSterility | CDL, KolkataCDSCO lab | Mar 2025 |
| Chloramphenirol Eye Ointment I.P. 1% W/W (EXPHENICOL) | 1624-366Mfg 2024-07 · Exp 2026-06 | Assay of ChloramphenicolAssay | CDL, KolkataCDSCO lab | Mar 2025 |
| Paracetamol Tab IP [Parayes -500 ) | 423- 1582Mfg 2023-09 · Exp 2026-08 | It fails the test ?Dissolution? Specified in the laboratory protocol as per IPDissolution | DTL ThiruvananthapuramState lab | Feb 2025 |
| Amoxycillin & Clavulanate Potassium for Oral Suspension I.P. 3.6gm/30ml | 724-37Mfg 2024-02 · Exp 2026-01 | Identification and Assay/Content of Clavulanic AcidAssay | RDTL GuwahatiCDSCO lab | Feb 2025 |
| Vitamin B- Complex with Vitamin C and Zinc Capsules (Nutribest-Plus ) | 1724-226Mfg 2024-05 · Exp 2025-10 | Assay of 'Cyanocobalami n' and 'Calcium Pantothenate'Assay | CDL KolkataCDSCO lab | Jan 2025 |
| Glipizide Tablets I.P. 5 mg | Z24-187Mfg 2024-02 · Exp 2026-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Sep 2024 |
| Gentamycin Sulphate Injection I.P. 40 mg/ml | 324-564Mfg 2024-05 · Exp 2026-04 | Description & Particulate matterDescription | CDL KolkataCDSCO lab | Sep 2024 |
| Ceftriiaxone Injection I.P. 1g | 324476Mfg 2024-04 · Exp 2026-03 | Particulate Matter & Clarity of SolutionParticulate matter | CDL KolkataCDSCO lab | Sep 2024 |
| Gentamicin Sulphate Injection I.P. 2 ml | 323-216Mfg 2023-03 · Exp 2025-02 | Description & Particulate matterDescription | CDL KolkataCDSCO lab | Jun 2024 |
| Gentamicin Sulphate Injection I.P. 2ml | 323-216Mfg 2023-03 · Exp 2025-02 | The sample does not conforms to I.P. with respect to the test for "Particulate matter" and is also not of standard quality for the reason stated under "Description"Description | CDL KolkataCDSCO lab | May 2024 |
| Dexamethasone Sodium Phosphate Injection I.P. (8mg/2ml) | 323-885Mfg 2023-08 · Exp 2025-07 | The sample does not conforms to IP with respect to test for "Free Dexamethasone", "Particulate matter,", "Extractable volume" ,"Assay of Dexamethasone Sodium Phosphate calculated as Dexamethasone Phosphate" and is also not of standard quality for the reason stated under "Description".Assay | CDL KolkataCDSCO lab | May 2024 |
| Ceftriaxone Injection I.P | 324-166Mfg 2024-02 · Exp 2026-07 | The sample does not complies to claim as per IP 2022in respect of test for appearance of solution, clarity of solution, particulate matter and sterility (Powder for Injection).Sterility | CDL KolkataCDSCO lab | May 2024 |
| Moxifloxacin & Prednisolone Acetate Eye Drops (MOXIZEE- P Eye Drops) | 1223-51Mfg 2023-02 · Exp 2025-01 | Assay of Prednisolone AcetateAssay | CDL KolkataCDSCO lab | Jan 2024 |
| Sodium Valporate Tablets IP 200 mg | 423-499Mfg 2023-03 · Exp 2025-02 | Dissolution of Sodium ValproateDissolution | RDTL ChandigarhState lab | Dec 2023 |
| MOXIZEE-P Eye Drops (Moxifloxacin & Prednisolone Acetate Eye Drops) | 1223-319Mfg 2023-08 · Exp 2025-07 | Assay of PrednisoloneAssay | CDL KolkataCDSCO lab | Dec 2023 |
| Tobramycin Ophthalmic Solution USP 0.3% w/v | 1223-108Mfg 2023-04 · Exp 2025-03 | Identification and Assay of Tobramycin Sulphate, pH and Minimum filled volumeAssay | RDTL ChandigarhCDSCO lab | Sep 2023 |
| Sodium Valproate and Valproic Acid Controlled Release Tablets 500 mg | 422-2202Mfg 2022-12 · Exp 2024-11 | Identification of Valproic Acid and Assay of Valproic Acid and Sodium ValproateAssay | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Itraconazole Capsules 100 mg | Z22-293Mfg 2022-03 · Exp 2024-02 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Amoxycillin & Potassium Clavulanate Tablets I.P. 625 mg | 422-494AMfg 2022-03 · Exp 2024-02 | AssayAssay | CDTL MumbaiCDSCO lab | Jul 2023 |
| Acetazolamide Tablets IP 250 mg | 423-27Mfg 2023-01 · Exp 2025-12 | Uniformity of weightUniformity of weight/content | RDTL ChandigarhCDSCO lab | Jun 2023 |
| MONAMOX-CL 625 (Amoxycillin& Potassium Clavulanate Tablets I.P.) | 422?1199Mfg 2022-08 · Exp 2024-01 | Assay and DissolutionAssay | CDTL MumbaiCDSCO lab | May 2023 |
| Paracetamol Oral Suspension I.P. 60 ml. (FOR PAEDIATRIC USE) | 622-412Mfg 2022-07 · Exp 2024-06 | AssayAssay | RDTL GuwahatiCDSCO lab | Apr 2023 |
| Taze (Piperacillin and Tazobactam Injection I.P.) | 322-350Mfg 2022-05 · Exp 2024-04 | Assay of TazobactumAssay | CDL KolkataCDSCO lab | Feb 2023 |
| Ceftriaxone and Sulbactam for Injection (Metifex SL 1500 Injection) | 322-797Mfg 2022-08 · Exp 2024-07 | Identification of Ceftriaxone Sodium and Sulbcatam Sodium, pH and Assay of Ceftriaxone Sodium calculated as Ceftriaxone and Sulbactam Sodium calculated as SulbactamAssay | RDTL ChandigarhCDSCO lab | Dec 2022 |
| Atenolol & Amlodipine Tablets I.P. 50mg/5mg | Z22-013Mfg 2022-01 · Exp 2023-12 | Dissolution (Amlodipine) and Assay/Content of AmlodipineAssay | RDTL GuwahatiState lab | Dec 2022 |
| Gabapentin Capsules IP 300 mg (GABATIX- 300 CAPSULES) | 1721-625Mfg 2021-11 · Exp 2024-10 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Nov 2022 |
| DIACOWIN-PLUS Capsules (Prebiotic & Probiotics Capsules) | 521-263Mfg 2021-09 · Exp 2023-08 | Identification of Bifidobacteruim specIes,Saccharomyces boulardi, Streptococcus thermophilus and Assay of Lactobacillus species, Bifidobacterium species, Saccharomyces boulardi and Streptococcus thermophilusAssay | CDL KolkataCDSCO lab | Oct 2022 |
| Vildazem M 1000 (Vildagliptin 50 mg & Metformin Hydrochloride 1000 mg Tablets I.P.) | 421-1467Mfg 2021-09 · Exp 2024-08 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Sep 2022 |
| Omeprazole Gastro-resistant Capsules I.P. | 520-170Mfg 2020-07 · Exp 2022-06 | DissolutionDissolution | RDTL GuwahatiState lab | May 2022 |
| NITZO -2.6 (Controlled Release Tablets of Nitrogylcerin) | 420-1291Mfg 2020-10 · Exp 2022-09 | AssayAssay | CDL KolkataCDSCO lab | Jan 2022 |
| LECETZY (Levocetirizine Tablets I.P.) | 420-1286Mfg 2020-10 · Exp 2022-09 | Dissolution and AssayAssay | CDL KolkataCDSCO lab | Nov 2021 |
| ATENOLOL AND AMLODIPINE TABLETS | Z20-660Mfg 2020-05 · Exp 2022-04 | Assay of AmlodipineAssay | RDTL ChandigarhCDSCO lab | Nov 2021 |
| Asonac-100 (Aceclofenac Tablets I.P.) | 420-576Mfg 2020-05 · Exp 2022-04 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2021 |
| XTER-250 (Terbinafine Tablets I.P. 250 mg) | 419-1282Mfg 2019-09 · Exp 2021-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Mar 2021 |
| RAMZE-5 (Ramipril Tablets I.P.) | 420-578Mfg 2020-05 · Exp 2022-04 | AssayAssay | CDL KolkataCDSCO lab | Feb 2021 |
| Nitzo - 2.6 (Controlled Release Tablets of Nitroglycerin) | 419-1544Mfg 2019-11 · Exp 2021-10 | Assay of Glyceryl TrinitrateAssay | CDL KolkataCDSCO lab | Jan 2021 |
| Zepara ? XT Tablets 650 mg (Paracetamol Tablets 650 mg) | 419-412Mfg 2019-03 · Exp 2021-02 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Jul 2020 |
| ZEPARA ?XT 650 mg (Paracetamol Tablets 650 mg) | 418-955Mfg 2018-10 · Exp 2020-09 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2019 |
| Pantoprazole For Injection (Panzel) | 318-7Mfg 2018-01 · Exp 2019-06 | Particulate ContaminationParticulate matter | RDTL GuwahatiState lab | Jun 2019 |
| (DEXAMETHASON E SODIUM PHOSPHATE INJECTION IP) | 317-936Mfg 2017-09 · Exp 2019-08 | Assay of Dexamethasone Sodium Phosphate Calculated as Dexamethasone PhosphateAssay | RDTL ChandigarhState lab | Apr 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.